NLS Pharmaceutics AG
0.01
-0.01 (-42.86%)
At close: Jan 15, 2025, 12:42 PM
0.01
0.00%
After-hours Jan 15, 2025, 12:42 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -73.77 -61.57 -54.82 -194.7 -236.45 -264.57 -204.55
PS Ratio n/a n/a n/a n/a n/a n/a n/a
PB Ratio -101.65 309.56 1.21K -62.01 -208.72 -154.5 -176.44
P/FCF Ratio -92.72 -73.18 -43.73 -763.8 -6.78K -498.27 -250.66
P/OCF Ratio -92.72 -73.18 -43.84 -763.8 -6.78K -498.27 -250.66
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio -0.18 n/a n/a -0.23 -0.14 -0.8 -1.15
Quick Ratio 0.23 2.76 2.40 0.04 0.09 0.04 2.30
Current Ratio 0.23 2.75 2.38 0.03 0.09 0.04 2.30
Asset Turnover n/a n/a n/a n/a n/a n/a n/a
Interest Coverage -81.34 -153.49 -174.08 -9.84 -5.12 -3.23 -6.48
Return on Equity (ROE) 1.38 -5.03 -22.02 0.32 0.88 0.58 0.86
Return on Assets (ROA) -6.59 -1.78 -2.07 -2.36 -7.82 -35.34 -2.91
Return on Capital (ROIC) 1.94 -2.62 -3.53 0.38 1.26 1.52 -4.44
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a

Create Price Alert on NLSPW

Your price alert will notify you when the stock price is above 0.01.

Add to Watchlist